Enter the first few characters of Company and click 'Go'

Quarterly Results of Glenmark Pharmaceuticals Ltd. Company(Figures in Rs crores)

	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Net Sales / Income	1,365.10	2,233.42	2,144.38	1,939.05	2,161.47
Other Income	258.81	46.22	49.36	232.97	89.73
Net Profit/Loss	-20.41	302.35	271.66	-137.47	430.50
Raw Material	701.17	807.03	796.76	777.09	711.70
Power And Fuel	0	0	0	0	0
Employee Expenses	379.56	383	334.47	306.12	357.17
Excise
Admin And Selling Expenses	0	0	0	0	0
Research And Devlopment Expenses	0	0	0	0	0
Expenses Capitalised	0	0	0	0	0
Other Expenses	552.57	566.46	551.25	644.60	617.59
Provisions Made	0	0	0	0	0
Interest	73.60	58.19	61.93	58.86	55.72
Gross Profit	0.94	458.88	472.42	391.78	472.84
Depreciation	51.16	49.85	48.75	46.73	46.22
Taxation	-55.09	87.01	120.39	-175.86	158.62
Extra Ordinary Item	-25.28	-19.67	-31.63	-658.37	162.50
Prior Year Adjustments	0	0	0	0	0
Equity Capital	28.22	28.22	28.22	28.22	28.22
Equity Dividend Rate	0	0	0	0	0
Agg.Of Non-Prom. Shares (in lacs)	0	0	0	0	0
Agg.Of Non PromotoHolding (%)	0	0	0	0	0
EPS (in Rs.)	-0.72	10.72	9.63	-4.87	15.26

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article